The medication might be safe during breastfeeding, but we do not have evidence to confidently state that it is
GLP-1 produces therapeutic effects via synchronized activities within the pancreatic, gastrointestinal, and central neurological systems, making it optimal for the dual control of diabetes and obesity (see to Table 1 for comprehensive mechanisms) (Ruze et al
Effect of Idebenone, Resveratrol and Taurine on the Sperm Quality and Lipid Peroxidation of Cryopreserved Crossbred Ram Semen
Immunity (2017) 46(3):393404
(2025) trial specifically tested semaglutide as an add-on to AID systems and found a 4.8 percentage point improvement in time in range (from 69.4% to 74.2%) alongside an 11.3-unit daily reduction in insulin, without any increase in hypoglycemia
Regular check-ups can assess the effectiveness of the treatment and make necessary modifications